BBIO technical analysis

BBIO Technical Analysis

Analysis date

August 7, 2026

Market

NasdaqGS (USD)

Daily cutoff

August 6, 2026

Reliability

Degraded

Informational use only. This page is not investment advice.

Data verification

BBIO Data Verification

Checking the latest completed daily bar for date and closing-price consistency before indicators are calculated.

Symbol
BBIO
Market
NasdaqGS
Currency
USD (US Dollar)
Latest completed bar
August 6, 2026

Historical prices are adjusted for corporate actions when applicable. The latest completed daily bar has a documented data-quality limitation, so interpret the indicators with additional caution.

Validation seriesLatest CloseDateDifferenceStatus
Calculation series81.99August 5, 2026-Verified
Verification series81.99August 5, 20260.00%Verified

Bottom line

BBIO Technical Analysis Summary

BBIO (BridgeBio Pharma) is in a clear bullish uptrend after a major rally, trading at 82.80 USD on August 6, 2026. The daily and weekly charts both show price above all key moving averages with a rising bullish stack (SMA20 above SMA50 above SMA200). RSI14 is 57.33 on the daily chart and 59.22 on the weekly chart, both positive but not overbought. The daily MACD line (1.67) is below its signal (2.28) with a negative histogram of -0.61, reflecting a short-term pullback from the recent high, while the weekly MACD (3.58 vs 2.41) remains clearly positive. Key support is at 78.82 (20-day low) and 62.50 (60-day low). Key resistance is at 91.00 (20-day high) and 93.42 (52-week high). A daily close above 91.00 would resume the uptrend toward 93.42, while a break below 78.82 would signal a deeper pullback. Because the independent verification series had not yet published the August 6 closing price when the check ran, reliability is Degraded and the indicators should be interpreted with additional caution.

Multi-timeframe dashboard

Multi-Timeframe Technical Dashboard

Comparing daily (2-year) and weekly (5-year) perspectives to identify aligned or conflicting signals.

Daily (August 6, 2026)

Trend
Bullish. Price at 82.80 is above SMA20 (82.62), SMA50 (75.15) and SMA200 (71.90), with all three in a rising bullish stack. The SMA200 has turned upward, confirming the longer-term trend improved during the 2026 rally. Price is right at the SMA20 after pulling back from the recent high near 91.00.
Momentum
Neutral to positive. RSI14 at 57.33 is above the 50 midline, showing positive but not overbought momentum. The MACD line at 1.67 sits below the signal line at 2.28 with a negative histogram of -0.61, indicating the short-term pullback is still in progress after the strong run. A turn of the histogram back above zero would confirm momentum is resuming to the upside.
Volatility
Moderate. ATR14 at 2.90 (3.50% of price) reflects normal daily swings for a biotech stock, well down from the wider ranges seen earlier in the year. Bollinger Bands (79.41 to 85.84) are moderately wide, with price in the middle of the band after the pullback from the upper band.
Volume
Below average. Latest volume of 1,171,017 is 51.1% of the 20-day average (2,290,111), indicating reduced participation during the recent pullback. Lower volume on the pullback suggests the decline has not been accompanied by aggressive selling so far.

Assessment

The daily chart shows a strong uptrend with price pulling back toward the SMA20 after printing a 20-day high near 91.00. The bullish SMA alignment and RSI above 50 support a constructive view, while the negative MACD histogram flags near-term momentum softening. The pullback is orderly as long as price holds above the SMA20 at 82.62 and the 20-day low at 78.82. A close back above 91.00 would resume the uptrend toward the 52-week high at 93.42, while a loss of 78.82 would open the door to a deeper retracement toward the 60-day low at 62.50.

Weekly (July 27, 2026 week)

Trend
Bullish. Price at 80.09 is above SMA20 (72.65), SMA50 (68.20) and SMA200 (36.80), with a clean bullish stack. The SMA200 has turned strongly upward, confirming a major trend change from the prior downtrend. The weekly structure remains constructive after the multi-month rally.
Momentum
Bullish. RSI14 at 59.22 is above 50, indicating positive momentum without overbought extremes. MACD at 3.58 is above the signal line at 2.41 with a positive histogram of 1.17, confirming the uptrend remains intact on the longer timeframe.
Volatility
Elevated but moderating. ATR14 at 7.05 (8.80% of price) reflects the wide weekly ranges of a biotech stock that has rallied strongly over the past year. Weekly Bollinger Bands (60.40 to 84.89) are wide, with price near the upper band after the recent advance.
Volume
Slightly below average. Weekly volume of 11,416,800 is 79.8% of the 20-week average (14,299,750). Participation has cooled modestly on the recent advance, so a renewed move on higher volume would be more convincing.

Assessment

The weekly chart is clearly bullish. Price is above all major moving averages in a bullish stack, RSI is positive, and the MACD is above its signal with a positive histogram. The stock has more than doubled over the trailing 60 weeks, and the 52-week position of 74.04% reflects strength without an extreme overextension. Key weekly support is the 20-week low at 62.50, and key resistance is the 52-week high at 93.42. As long as weekly closes hold above the SMA20 at 72.65, the uptrend is intact.

Key indicators

BBIO Key Technical Indicators

RSI, MACD, moving averages, ATR, and Bollinger Bands across daily and weekly timeframes.

IndicatorDailyWeekly
RSI (14)57.3359.22
MACD (12, 26, 9)1.67 / 2.28 / -0.613.58 / 2.41 / 1.17
ATR (14)2.90 (3.50%)7.05 (8.80%)
Bollinger Bands (20, 2)79.41 - 85.8460.40 - 84.89
SMA (20)82.6272.65
SMA (50)75.1568.20
SMA (200)71.9036.80

Price structure

BBIO Price Structure and Returns

Price performance across multiple lookback periods and 52-week position.

MetricDailyWeekly
Current Price82.8080.09
1-Period Return+0.99%-4.68%
5-Period Return+0.80%+14.02%
20-Period Return-8.17%+15.39%
60-Period Return+28.01%+107.38%
252-Period Return+68.26%+67.76%
52-Week Low42.0942.09
52-Week High93.4293.42
52-Week Position79.32%74.04%

Key levels

BBIO Support and Resistance Levels

Key price levels based on recent swing highs and lows across daily and weekly timeframes.

LevelDailyWeekly
20-Period High91.0093.42
20-Period Low78.8262.50
60-Period High93.4293.42
60-Period Low62.5038.58

Scenarios

BBIO Technical Scenarios

Conditions, invalidation triggers, and what to watch for each scenario.

Bullish

Trigger

Price closes above the 20-day high at 91.00 on above-average volume, the daily MACD histogram turns positive, and price pushes toward the 52-week high at 93.42.

Invalidation

Price falls below the 60-day low at 62.50.

What to watch

Sustained closes above 91.00; weekly MACD histogram continuing to expand; RSI holding above 50 on daily pullbacks; volume picking up on up-days.

Range-Bound

Trigger

Price oscillates between 78.82 support and 91.00 resistance, with the daily MACD histogram oscillating around zero.

Invalidation

A decisive break of either boundary with increasing volume.

What to watch

RSI hovering between 45 and 60; daily MACD histogram staying flat; volume fading near resistance at 91.00.

Bearish

Trigger

Price breaks below the 20-day low at 78.82 and then the 60-day low at 62.50, confirming a deeper retracement.

Invalidation

Price reclaims the SMA20 (82.62) and holds above it.

What to watch

Sustained closes below SMA20 (82.62); increasing downside volume; daily MACD histogram turning more negative.

Methodology

Methodology and Limitations

This technical analysis is calculated locally from adjusted OHLCV history. The daily series ends August 6, 2026, and the weekly series ends July 27, 2026 week. The latest completed daily bar has a documented data-quality limitation. Historical prices are adjusted for corporate actions when applicable. Indicators include Wilder RSI(14), MACD(12,26,9), SMA20/50/200, Wilder ATR(14), Bollinger Bands(20,2), relative volume, multi-period returns, and price-range levels. Support and resistance are descriptive zones, not guaranteed reversal points. Historical patterns do not predict future prices, and this page is not investment advice.

Frequently Asked Questions

This technical analysis is for informational and educational purposes only. It does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. Past performance and historical patterns are not guarantees of future results. All investments carry risk, including the potential loss of principal. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.

Market data is checked for date and closing-price consistency before indicators are calculated. Data cutoffs: daily August 6, 2026, weekly July 27, 2026 week. Generated August 7, 2026.